Mantle Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Mantle Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma [Phase 1, Phase 2]
Clinical trial update on CD19-targeted CAR-T cell therapy being tested in relapsed/refractory leukemias and lymphomas (Phase 1 and Phase 2).
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007) [Phase 2]
This is a Phase 2 safety evaluation of combining ibritumomab tiuxetan (Zevalin) with a fludarabine-based reduced-intensity conditioning regi…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma. [Phase 2]
Phase 2 trial evaluating Rituximab added to standard chemotherapy in untreated mantle cell lymphoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL) [Phase 2]
A Phase 2 trial assessing salvage therapy with lenalidomide plus dexamethasone in patients with relapsed or refractory mantle cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma [Phase 1, Phase 2]
Clinical trial update for PCAR-019 evaluating efficacy and safety in CD19-positive relapsed or refractory leukemia and lymphoma across Phase…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL) [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and initial efficacy of Obatoclax Mesylate in combination with Bortezomib for relapsed or refractory mantle…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma [Phase 2]
A Phase 2 trial evaluated whether combination chemotherapy followed by peripheral stem cell transplantation is feasible for mantle cell lymp…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy and rituximab with peripheral stem cell transplantation for mantle cell lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy [Phase 2]
This entry reports on a Phase 2 trial evaluating ibrutinib for mantle cell lymphoma in patients who progressed after bortezomib, with the st…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma [Phase 2]
Phase 2 trial evaluating SyB L-0501 in combination with rituximab for untreated low-grade B-cell non-Hodgkin lymphoma and mantle cell lympho…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
This clinical trial update reports a completed retrospective study of temsirolimus in renal cell carcinoma and mantle cell lymphoma. Results…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating vorinostat plus FND in relapsed or refractory mantle cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 study evaluating SAR245409 in combination with rituximab or bendamustine plus rituximab in patients with indolent non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Study of Mantle Cell Lymphoma Treatment by RiBVD [Phase 2]
A Phase 2 clinical trial evaluating the RiBVD regimen for mantle cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating a combination of Rituximab, Bortezomib, Bendamustine, and Dexamethasone in patients with Mantle cell lym…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL) [Phase 2]
Phase 2 pilot trial of oral vorinostat plus eltrombopag in lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for MORAb-004 in young patients with recurrent or refractory solid tumors or lymphoma; the study has been completed.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of obatoclax with bortezomib in adults with aggressive relapsed or recurrent non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of lenalidomide plus rituximab as maintenance therapy for adult B-cell non-Hodgkin lymphoma is noted as terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study of Repeat Intranodal Injections of Ad-ISF35 [Phase 2]
Phase 2 study of repeat intranodal injections of Ad-ISF35 in various non-Hodgkin lymphomas was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma [Phase 2]
Phase 2 study evaluating the R-MACLO-IVAM regimen with thalidomide in untreated mantle cell lymphoma; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating everolimus in relapsed or refractory mantle cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 study evaluating the combination of methoxyamine and fludarabine phosphate in adults with relapsed or refractory hematologic maligna…
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715) [Phase 2]
A Phase 2 study of SCH 727965 in mantle cell lymphoma or B-cell chronic lymphocytic leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]
Phase 1 study sponsored by the National Cancer Institute evaluating dasatinib in patients with metastatic or unresectable solid tumors and l…